Largest genetic study of heart failure finds new risk factors

In a new study co-led by investigators at the United States Department of Veterans Affairs and Brigham and Women’s Hospital, a founding member of the Mass General Brigham healthcare system, a global team of scientists conducted one of the largest genetic association studies on heart failure to date.

Roche details Columvi OS data in quest for expanded lymphoma approval

Roche released detailed data at the European Hematology Association congress for its CD20xCD3 bispecific antibody Columvi in earlier lines of large B cell lymphoma, showing

June 15, 2024

Opinion | Hospitalization Should Not Mean Financial Ruin for Medicare Beneficiaries

Chatterjee is a physician, health policy researcher, and an assistant professor of medicine. Macneal is a statistical analyst. Patel is a senior research coordinator. Medicare

December 9, 2024

Merck partners with Hengrui in deal worth up to $1.48bn – Pharmaceutical Technology

The deal gives Merck the worldwide rights for both assets outside of China. Image credit: Shutterstock/OleksSH. Merck KGaA (Merck) is expanding its oncology portfolio after

October 30, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.